2013 News
OXFORD, UK and BERLIN CHEMIE/MENARINI, GERMANY – 9th December 2013 – Oxford BioTherapeutics (OBT) and Berlin-Chemie (Menarini Group) announce today that they have designated a novel enhanced antibody targeting acute myeloid leukemia...
Portfolio company Zysis, a private pharmaceutical company optimising therapies for disorders of the Central Nervous System, today announced that the United States Patent and Trademark Office has granted U.S. patent 8,575,172 covering its Phase I...
Portfolio company Accutronics has received a Smart Award from the UK’s innovation agency, the Technology Strategy Board. The company received a £100,000 grant to support ‘proof of concept’ work on a new high voltage...
Cambridgeshire, UK, 31 October 2013 ... Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has received a patent for its Heat Elution Sample Preparation, technology which has the potentia...
London, UK and Vienna, Austria, 15 October 2013 - PolyTherics Limited (“PolyTherics”) and TUBE Pharma GmbH (“TUBE”) announce that they are collaborating to produce reagents to link novel cytotoxic drugs developed by TUBE...